MedPath

Evaluation of the Performance of Two Contact Lenses Compared to a Marketed Lens

Not Applicable
Completed
Conditions
Refractive Ametropia
Registration Number
NCT01484028
Lead Sponsor
Johnson & Johnson Vision Care, Inc.
Brief Summary

This study will serve to evaluate and compare the performance of two new lenses to a marketed lens.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
275
Inclusion Criteria
  • Healthy, female adult, at least 18 years of age, and no more than 34 years of age
  • The subjects must be female, light eye Caucasian, Non-Hispanic, habitual soft contact lens wearer (both eyes) with light or dark eyes
  • Must have rated the Concept Statement positively (i.e., a rating of 4 or 5).
  • Optimal vertexed spherical equivalent distance correction must be between -1.00 and -4.00 diopters (D)
  • Any cylinder power must be: <=0.75D
  • Visual acuity must be best correctable to 20/25 or better for each eye
  • Must have normal eyes (no ocular medications or ocular infection of any type)
  • Must read and sign the Statement of Informed Consent
  • Must appear able and willing to adhere to the instructions set forth in this clinical protocol.
Exclusion Criteria
  • Ocular or systemic allergies or disease which might interfere with contact lens wear
  • Systemic disease, autoimmune disease, or use of medication which might interfere with contact lens wear
  • Clinically significant (grade 3 or worse) corneal edema, corneal neovascularization, corneal staining, or any other abnormalities of the cornea which would contraindicate contact lens wear
  • Clinically significant (grade 3 or 4) tarsal abnormalities or bulbar injection which might interfere with contact lens wear
  • Any ocular infection
  • Any corneal distortion resulting from previous hard or rigid gas permeable contact lens wear
  • Any color deficiencies (colorblindness) - to the best of the subject's knowledge
  • Pregnancy or lactation
  • Diabetes
  • Infectious diseases (e.g. hepatitis, tuberculosis) or an immuno-suppressive disease (e.g. HIV)
  • Habitual contact lens type is toric, multifocal, or is worn as extended wear.
  • Subject presents with one dark iris color and one light iris color.
  • Subject has heterochromia iridis (a difference in color between parts of one iris).
  • The subject must not be an employee or family member of the clinical study site.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Lens Fit AcceptanceDispensing

The overall lens fit was evaluated by the Investigators for each eye whether it was acceptable (yes/no).

Monocular Visual AcuityDispensing

Monocular distance Snellen visual acuity (VA) scores were coverted to the algorithm of the minimal angle of resolution (LogMAR) scale based on the following formula: LogMAR = Log10 (VA/20) - a\*VAR, where Log10 = base 10 logarithm, VA = the Snellen denominator score, a = LogMAR stepsize coefficient and VAR = letter gained or missing in addition to the Snellen denominator score.

Corneal Staining of Grade 3 or 4After 7-9 days of lens wear

Corneal staining was graded using a 5-point scale; 0=None(no staining), 1=Trace, 2=Mild, 3=Moderate, and 4=Severe. Only those eyes with corneal staining grade \>= 3 were reported.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (15)

Advanced Optometry

🇺🇸

Mission Viejo, California, United States

James R Dugue, Optometrist

🇺🇸

Mission Viejo, California, United States

Advance Eye Care

🇺🇸

Pismo Beach, California, United States

Golden Vision

🇺🇸

Sarasota, Florida, United States

Eye Associates of Winter Park

🇺🇸

Winter Park, Florida, United States

Eye Care Associates

🇺🇸

Bloomington, Illinois, United States

Kannarr Eye Care

🇺🇸

Pittsburg, Kansas, United States

Vision Care

🇺🇸

East Lansing, Michigan, United States

Spectrum Eye Care

🇺🇸

Jamestown, New York, United States

Sacco Eye Group

🇺🇸

Vestal, New York, United States

Scroll for more (5 remaining)
Advanced Optometry
🇺🇸Mission Viejo, California, United States
© Copyright 2025. All Rights Reserved by MedPath